![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
中东和非洲血脑屏障技术市场预测至 2028 年 - COVID-19 影响和技术区域分析(双特异性抗体 RMT 方法、特洛伊木马方法、增加渗透性、被动扩散和其他非侵入性 BBB 技术)和应用(阿尔茨海默病)疾病、癫痫、帕金森病、多发性硬化症、亨特综合症、脑癌等)
市场介绍
中东及中东地区非洲地区包括沙特阿拉伯、南非、阿联酋和中东和非洲其他地区。沙特阿拉伯是血脑屏障技术市场的最大市场。由于医疗保健意识的增强和神经退行性疾病的增加,预计沙特阿拉伯的血脑屏障技术市场在预测期内收入将强劲增长。人们对健康问题的认识提高和医疗保健服务消费的增加维持了各种疗法和治疗的巨大市场。沙特阿拉伯政府正在努力改善该国人民的生活。医疗保健服务的改善在过去几年中已从 2006 年占政府总预算的 5.9% 增加到 2014 年的 7.0%。在沙特阿拉伯,医疗保健需求不断增加,政府采取的举措有利于提高民众的参与度私营部门,以扩大私营部门和投资者的规模。
阿联酋和沙特阿拉伯等国家也登记了大量阳性患者。 COVID-19 大流行已成为该地区最重大的挑战。对于该地区脆弱且饱受冲突蹂躏的国家来说,这一挑战尤其令人恐惧——例如伊拉克(1,963,264)、苏丹(38,000)、伊朗(5,378,408)、以色列(1,202,212)和也门(8,527),因为这将导致减少由于全球贸易中断导致进口增加,这进一步加剧了医疗用品和其他商品的短缺,导致价格大幅上涨。由于更多关于血脑屏障技术与COVID-19感染的关系及其对人体影响的研究,本次大流行中的血脑屏障技术市场正在不断增长。因此,大流行对血脑屏障技术市场产生积极影响。
市场概况和动态
中东和中东地区的血脑屏障技术市场非洲市场预计将从 2021 年的 4351 万美元增长到 2028 年的 1.9672 亿美元。预计 2021 年至 2028 年,该市场的复合年增长率为 24.1%。一些神经系统疾病,如中风、神经病、阿尔茨海默病和帕金森病在老年人中更为常见,并且其患病率随着预期寿命的延长而增加。据世界卫生组织称,全球人口正在迅速老龄化。 2015 年至 2050 年间,世界 60 岁以上人口将增加近一倍,从 12% 增至 22%,而老年人中的精神和神经系统疾病可能占到这一时期总伤残调整生命年 (DALY) 的 6.6%年龄阶层。此外,根据同一来源,大约 15% 的 60 岁及以上成年人患有精神障碍。根据疾病预防控制中心 (CDC) 的数据,阿尔茨海默病是 65 岁及以上人群的第五大死因。此外,患有阿尔茨海默病的人数每五年就会翻一番。此外,由于神经系统疾病导致的死亡率也在增加。例如,根据阿尔茨海默氏症协会的数据,三分之一的老年人死于阿尔茨海默氏症或痴呆症。因此,与年龄相关的神经系统疾病患病率的上升增加了血脑屏障技术或更好的药物输送。这一因素正在推动血脑屏障技术市场的增长。
关键细分市场
在技术方面,增加渗透率细分市场在中东和非洲地区占据最大份额。 2021年非洲血脑屏障技术市场。从应用来看,帕金森病细分市场占据中东和非洲地区最大份额。 2021年非洲血脑屏障技术市场。
主要来源和上市公司
准备这份关于中东和中东地区血脑屏障技术市场的报告时提到了一些主要的一手和二手资料来源。非洲有公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有梯瓦制药工业有限公司(Teva Pharmaceutical Industries Ltd.); F.霍夫曼-拉罗氏有限公司;礼来公司;百时美施贵宝公司;辉瑞公司;和强生公司Johnson Services, Inc. 等。
购买报告的理由
- 了解中东和中东地区非洲血脑屏障技术市场格局并确定最有可能保证强劲回报的细分市场
- 了解中东不断变化的竞争格局,保持领先地位&非洲血脑屏障技术市场
- 高效规划中东和非洲地区的并购和合作交易通过确定最有希望销售的细分市场,非洲血脑屏障技术市场
- 通过对中东各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策&非洲血脑屏障技术市场
- 获取2021-2028年中东和非洲各细分市场的市场收入预测非洲地区。
中东和非洲地区非洲血脑屏障技术市场细分
中东和非洲非洲血脑屏障技术市场 –按技术
- 双特异性抗体RMT方法
- 特洛伊木马方法
- 增加渗透性
- 被动扩散
- 其他非侵入性 BBB 技术
中东和中东地区非洲血脑屏障技术市场 –通过应用
- 阿尔茨海默病
- 癫痫
- 帕金森病
- 多发性硬化症
- 猎人综合症
- 脑癌
- 其他 >
中东和中东地区非洲血脑屏障技术市场 –按国家/地区
- 沙特阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区
中东及中东地区非洲血脑屏障技术市场 –提及的公司
- 梯瓦制药工业有限公司 ;
- F.霍夫曼罗氏有限公司 ;
- 礼来公司和公司   ; &n公共服务提供商; &n公共服务提供商;
- 百时美施贵宝公司   ; &n公共服务提供商;
- 辉瑞公司 ; ;
- 强生公司约翰逊服务公司   ;
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Blood Brain Barrier Technologies Market – By Technology
1.3.2 Middle East & Africa Blood Brain Barrier Technologies Market – By Application
1.3.3 Middle East & Africa Blood Brain Barrier Technologies Market– By Country
2. Middle East & Africa Blood Brain Barrier Technologies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Blood Brain Barrier Technologies Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Middle East & Africa Blood Brain Barrier Technologies Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Fostering Prevalence of Neurological Disorders
5.1.2 Scaling Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders
5.2 Market Restraints
5.2.1 Hurdles in Brain Medication Delivery
5.3 Market Opportunities
5.3.1 Higher Number of Product Approvals and Launches
5.4 Future Trends
5.4.1 Elevating Demand Nanoparticles for Brain Drug Delivery
5.5 Impact Analysis
6. Middle East & Africa Blood Brain Barrier Technologies – Market Analysis
6.1 Middle East & Africa Blood Brain Barrier Technologies Market Revenue Forecast and Analysis
7. Middle East & Africa Blood Brain Barrier Technologies Market Analysis – by Technology
7.1 Overview
7.2 Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)
7.3 Bispecific Antibody RMT Approach
7.3.1 Overview
7.3.2 Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Trojan Horse Approach
7.4.1 Overview
7.4.2 Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Increasing Permeability
7.5.1 Overview
7.5.2 Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Passive Diffusion
7.6.1 Overview
7.6.2 Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Other Non-Invasive BBB Technologies
7.7.1 Overview
7.7.2 Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Blood Brain Barrier Technologies Market Analysis – By Application
8.1 Overview
8.2 Middle East & Africa Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)
8.3 Alzheimer’s Disease
8.3.1 Overview
8.3.2 Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Epilepsy
8.4.1 Overview
8.4.2 Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Parkinson’s Disease
8.5.1 Overview
8.5.2 Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Multiple Sclerosis
8.6.1 Overview
8.6.2 Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Hunter’s Syndrome
8.7.1 Overview
8.7.2 Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Brain Cancer
8.8.1 Overview
8.8.2 Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Blood Brain Barrier Technologies Market – Country Analysis
9.1 Overview
9.1.1 Middle East & Africa: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)
9.1.1.1 Saudi Arabia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 Saudi Arabia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 Saudi Arabia: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.1.3 Saudi Arabia: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.2 South Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 South Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 South Africa: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.2.3 South Africa: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.3 UAE: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 UAE: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 UAE: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.3.3 UAE: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
9.1.1.4 Rest of Middle East & Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Rest of Middle East & Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Rest of Middle East & Africa: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)
9.1.1.4.3 Rest of Middle East & Africa: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Middle East & Africa Blood Brain Barrier Technologies Market
10.1 Impact Assessment of COVID-19 Pandemic
11. Middle East & Africa Blood Brain Barrier Technologies Market– Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Teva Pharmaceutical Industries Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Eli Lilly and Company
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bristol-Myers Squibb Company
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson and Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Blood Brain Barrier Technologies Market – Revenue, and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. South Africa: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 5. South Africa: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of Middle East & Africa: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of Middle East & Africa: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Organic Developments Done By Companies
Table 11. Inorganic Developments Done By Companies
Table 12. Glossary of Terms, Blood Brain Barrier Technologies Market
LIST OF FIGURES
Figure 1. Middle East & Africa Blood Brain Barrier Technologies Market Segmentation
Figure 2. Middle East & Africa Blood Brain Barrier Technologies Market Segmentation, By Country
Figure 3. Middle East & Africa Blood Brain Barrier Technologies Market Overview
Figure 4. Increasing Permeability Segment Held the Largest Share by Technology in Blood Brain Barrier Technologies Market
Figure 5. The UAE to Show Significant Growth During Forecast Period
Figure 6. Middle East & Africa Blood Brain Barrier Technologies Market, Industry Landscape
Figure 7. Middle East & Africa PEST Analysis
Figure 8. Middle East & Africa Blood Brain Barrier Technologies Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 9. Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)
Figure 10. Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Middle East & Africa Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)
Figure 16. Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East & Africa: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. Middle East & Africa: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)
Figure 25. Saudi Arabia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. South Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. UAE: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Middle East & Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Pfizer, Inc.
- Johnson & Johnson Services, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa blood brain barrier technologies market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa blood brain barrier technologies market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the blood brain barrier technologies market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution